CTIS2024-513459-34-00招募中1 期
A prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab together with donor bone marrow infusion in HLA-mismatched living donor kidney transplant recipients (Trex) - Trex001
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •For recipients (study and control group): Patient has provided written informed consent., For donors (study group only): Participant is 18 years or older., For donors (study group only): Participant is suitable to donate bone marrow according to the guidelines of the Department of Blood Group Serology and Transfusion Medicine., For donors (study group only): WOCBP must not be pregnant at inclusion (i.e. negative pregnancy test)., For donors (control group only): Participant has provided written informed consent to donate blood for immune monitoring analyses., For donors (control group only): Participant is 18 years or older., For recipients (study and control group): Patient is 18 years or older., For recipients (study and control group): Patient is a planned recipient of a living donor kidney transplant., For recipients (study and control group): Patient is a planned recipient of an ABO-compatible kidney graft., For recipients (study and control group): Patient is a planned recipient of a kidney graft from a donor that is not HLA-identical., For recipients (study and control group): Patient is negative for DSA., For recipients (study and control group): WOCBP must have a negative pregnancy test at inclusion., For recipients (study and control group): WOCBP must be using an adequate method of contraception to avoid pregnancy throughout the study and for up to 12 weeks after the study in such a manner that the risk of pregnancy is minimized., For donors (study group only): Participant has provided written informed consent.
排除标准
- •For recipients (study and control group): Patient is EBV-negative on serology., For recipients (study and control group): Patient is HIV-positive or suffering from chronic viral hepatitis., For recipients (study and control group): Patient is CMV-negative and receiving a kidney from a CMV-positive donor., For recipients (study and control group): Positive T-cell lymphocytotoxic cross match., For recipients (study and control group): Patient with prior kidney transplant or non-renal solid organ transplant., For recipients (study and control group): Patient has a known contraindication to any of the protocol-specified treatments, For recipients (study and control group): Patient had been diagnosed with a malignancy within 5 years prior to study entry, excluding non-metastatic basal or squamous cell carcinoma of the skin., For recipients (study and control group): Female patients who are breast-feeding., For recipients (study and control group): Female patients with a positive pregnancy test.
研究者
相似试验
招募中
2 期
A prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab together with donor bone marrow infusion in HLA-mismatched living donor kidney transplant recipients (Trex)2024-513459-34-00Medical University Of Vienna24
已完成
不适用
To Study the safety and effectiveness of Laser Treatment in Glaucoma patientsCTRI/2017/03/008071Aleyegn Technologies LLC5
进行中（未招募）
1 期
A prospective, randomised study to assess safety, changes in platelet reactivity, plasma cardiac biomarkers and metabolic parameters over 48 weeks in HIV-1 infected subjects undergoing a switch in antiretroviral therapy. - The St. Marys and The Mater Switch Study (SMASH)HIVEUCTR2009-011538-93-GBImperial College London18
进行中（未招募）
2 期
Study to evaluate the safety and efficacy of the Versius surgical system in robot-assisted cholecystectomy (a surgical procedure to remove your gallbladder)Robot assisted cholecystectomySurgeryISRCTN17254664CMR Surgical (United Kingdom)30
进行中（未招募）
2 期
Study to evaluate the safety and efficacy of the Versius surgical system in robot-assisted cholecystectomy (a surgical procedure to remove your gallbladder)ISRCTN48886202CMR Surgical (United Kingdom)30